Whitehawk Therapeutics (WHWK) Receivables (2016 - 2024)
Whitehawk Therapeutics (WHWK) reported Receivables of $5.9 million for Q4 2024, up 7.56% year-over-year from $5.5 million in Q1 2024, and down 9.74% on a QoQ basis from $6.5 million in Q3 2024.
Whitehawk Therapeutics (WHWK) has 6 years of Receivables data on file, last reported at $5.9 million in Q4 2024.
- Quarterly Receivables rose 7.56% year-over-year to $5.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.9 million (up 7.56% YoY) and the FY2024 annual result came in at $5.9 million, up 7.56% from the prior year.
- Receivables eased to $5.9 million in Q4 2024 per WHWK's latest filing, from $6.5 million in the prior quarter.
- Across five years, Receivables topped out at $14.1 million in Q4 2020 and bottomed at $1.9 million in Q4 2022.
- The 4-year median for Receivables is $5.5 million (2023), against an average of $5.1 million.
- The widest annual swing landed in 2023, when Receivables jumped 194.74%; it then dropped 11.36% in 2024.
- Tracing WHWK's Receivables over 4 years: stood at $14.1 million in 2020, then slumped by 86.84% to $1.9 million in 2022, then jumped by 194.74% to $5.5 million in 2023, then increased by 7.56% to $5.9 million in 2024.
- Per Business Quant, the three latest WHWK Receivables figures stand at $5.9 million (Q4 2024), $6.5 million (Q3 2024), and $5.9 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | 5.72 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 5.57 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 2.26 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2020 | 14.15 Mn |
| Sep 30, 2017 | 39,246.00 |
| Jun 30, 2017 | 4,264.00 |
| Mar 31, 2017 | 32,453.00 |
| Dec 31, 2016 | 4,157.00 |